Wade W Sugden, PhD1, Zachary LeBlanc1*, Mayuri Tanaka-Yano, PhD1, Ran Jing2*, Maria Gonzalez di Tillio1*, Mohamad Najia, PhD1*, Yang Tang1*, Elizabeth Molnar1*, Stephan George1*, Brittney Love1*, Caroline Kubaczka1*, Nan Liu1*, Nah-Young Shin, PhD1*, Thorsten M. Schlaeger, PhD2*, Edroaldo Lummertz da Rocha, PhD3*, Alan B. Cantor, MD, PhD4, Stuart H Orkin, MD1, Robert Grant Rowe1, Wolfram Goessling, MD, PhD5, George Q. Daley, MD, PhD1 and Trista E. North, PhD6
1Department of Hematology/Oncology, Harvard Medical School/Boston Children's Hospital, Boston, MA
2Harvard Medical School/Boston Children's Hospital, Boston, MA
3Graduate Program of Pharmacology, Federal University of Santa Catarina, Florianopolis, Brazil
4Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5Brigham and Women's Hospital, Boston, MA
6Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA